Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Qureshi, Asaf A ^a,b   Karpen, Charles W ^c   Qureshi, Nilofer ^a,d   Papasian, Christopher J ^a   Morrison, David C ^a   Folts, John D ^e  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b Advanced Medical Research   (United States)

^c Prairie Cardiovascular Consultants Ltd   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e Cardiovascular Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; BETA TOCOPHEROL; COLLAGEN; DELTA TOCOPHEROL; DELTA TOCOTRIENOL; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; PALM OIL; TOCOPHEROL; TOCOPHEROL DERIVATIVE; TOCOTRIENOL RICH FRACTION; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT;

ARTICLE; BETA TOCOTRIENOL; CHROMATOGRAPHY; CORONARY ARTERY OBSTRUCTION; CYCLIC FLOW REDUCTION; DOG; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG STRUCTURE; FLOW RATE; HEMATOCRIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; NONHUMAN; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOGENESIS; ANIMAL; BLOOD; COMPARATIVE STUDY; PATHOLOGY; THROMBOCYTE; THROMBOSIS;

CANIS FAMILIARIS;

ADENOSINE DIPHOSPHATE; ALPHA-TOCOPHEROL; ANIMALS; BLOOD PLATELETS; COLLAGEN; CORONARY STENOSIS; DOGS; HEMATOCRIT; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; THROMBOSIS; TOCOTRIENOLS;

EID: 79953885203     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-58     Document Type: Article

References (66)

1. Dietary guidelines for healthy American adults: A statement for physicians and health professionals by the Nutrition Committee. American Heart Association. RM Krauss RJ Deckelbaum N Ernst E Fisher BV Howard RH Knopp T Kotchen AH Lichtenstein HC McGill TA Pearson TE Prewitt NJ Stone LV Horn R Weinberg, Circulation 1996 94 7 1795 1800 8840887 (Pubitemid 26320303)
2. Nutrition and Your Health. U.S Department of Agriculture. U.S. Department of Health and Human Services, Dietary Guidelines for Americans Washington, DC: U.S. Printing Office, Home and Garden Bulletin No 4 1995 232
3. Role of oxidized low density lipoprotein in atherogenesis. JL Witztum D Steinberg, J Clin Invest 1991 88 1785 1792 10.1172/JCI115499 1752940
4. Role of oxidized low density lipoprotein in atherogenesis. S Parthasarathy SM Renkin, Prog Lipid Res 1992 92 127 143 10.1016/0163-7827(92) 90006-5
5. The role of oxidized lipoproteins in atherogenesis. JA Berliner JW Heinecke, Free Radical Biol Med 1996 20 707 727 10.1016/0891-5849(95)02173-6 (Pubitemid 26105783)
6. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. D Steinberg S Parthasarathy TE Carew, N Engl J Med 1989 320 915 924 10.1056/NEJM198901053200122 2648148 (Pubitemid 19101597)
7. Vitamin E in human health and disease. MW Clark, Clin Laboratory Sciences 2008 45 5 417 430 10.1080/10408360802118625
8. Vitamin E decrease heart attack risk? Summary and implications with respect to dietary recommendations. MG Traber, J Nutr 2001 131 395S 397S 11160568 (Pubitemid 32115388)
9. Vitamin E supplementation and cardiovascular events in high-risk patients. S Yusuf, N Engl J Med 2000 342 3 154 160 10.1056/NEJM200001203420302 10639540 (Pubitemid 30051646)
10. Tocopherol-mediated peroxidation of lipoproteins: Implication for vitamin E as potential antiatherogenic supplement. JM Upston AC Terentis R Stocker, FASEB J 1999 13 977 994 10336881 (Pubitemid 29249724)
11. Dose-response comparison of RRR - tocopherol and all-racemic -tocopherol on LDL oxidation. S Deveraj B Adams-Huet CJ Fuller I Jialal, Arterio Throm Vasc Biol 1997 17 2273 2279 (Pubitemid 28057132)
12. Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcome prevention evaluation study investigators, N Engl J Med 2000 342 154-160
13. Meta analysis: High dose of vitamin E supplementation may increase all-cause mortality. ER Miller III R Pastor-Barriuso D Dalal RA reimersma LJ Appel E Guallar, Ann Intern Med 2005 142 947 951
14. Adhesion of human platelets inhibited by vitamin E. PD Richardson M Steiner, Vitamin E in health and disease Mercel Decker: New York, Packer L, Fuchs J, 1993 297 311
15. Platelets and aging: Aggregation, arachidonate metabolism and antioxidant status. E Vericel M Croset P Sedivy, Thrombosis Res 1988 49 331 342 10.1016/0049-3848(88)90313-1
16. Reduction of platelet adhesiveness by vitamin E supplementation in humans. J Jandak M Steiner PD Richardson, Thrombosis Res 1988 49 393 404 10.1016/0049-3848(88)90242-3
17. Dietary supplementation with vitamin E in hyperlipoproteinemias: Effects on plasma lipid peroxide, antioxidant activity, prostacyclin generation & platelet aggregability. A Szczeklik RJ Gryglewski B Domagala, Thromb Haemostas 1985 54 425 430 (Pubitemid 16252464)
18. Effect of alpha-tocopherol administration on platelet function in man. M Steiner, Thromb Haemostas 1983 49 636 640
19. Chemical reactivities and physical effects In comparison between tocopherols and tocotrienols: Physiological significance and prospects as antioxidant. Y Yoshida Y Saito LS Jones Y Shigeri, J biosci & Bioeng 2007 104 6 439 445
20. Dose-dependent elevation of plasma tocotrienols levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. AHG Rasool KH Yuen K Yusoff AR Wong ARA Rahman, J Nutr Sci Vitaminol 2006 52 473 478 10.3177/jnsv.52.473 17330512 (Pubitemid 46292983)
21. Comparative study on the action of tocopherols and tocotrienols as antioxidant: Chemical and physical effects. Y Yoshida E Niki N Noguchi, Chem Phys Lipids 2003 123 63 75 10.1016/S0009-3084(02)00164-0 12637165 (Pubitemid 36287652)
22. Molecular aspects of α-tocotrienol antioxidant action and cell signaling. L Packer SU Weber G Rimbach, J Nutr 2001 131 369S 373S 11160563 (Pubitemid 32115383)
23. Isolation and structural identification of Novel tocotrienols from rice bran with hypocholesterolemic, antioxidant and antitumor properties. AA Qureshi H Mo L Packer DM Peterson, J Agr Food Chem 2000 48 3130 3140 10.1021/jf000099t
24. The chemistry and antioxidant properties of tocopherols and tocotrienols. A Kamal-Eldin LA Appelqvist, Lipids 1996 31 671 701 10.1007/BF02522884 8827691 (Pubitemid 26240763)
25. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system in rat and human lipoproteins. C Suarna RL Hood RT Dean R Stocker, Biochem Biophys Acta 1993 1166 163 170 8443232 (Pubitemid 23060889)
26. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. E Serbinova V Kagan D Han L Packer, Free Radic Biol Med 1991 10 263 275 10.1016/0891-5849(91)90033-Y 1649783 (Pubitemid 121003898)
27. Effects of tocopherols & tocotrienols on the physicochemical property of the liposomal membrane in relation to their antioxidant activity. M Yamaoka MJH Carrillo, Chem Phys Lipids 1990 55 295 300 10.1016/0009-3084(90)90167-P (Pubitemid 20350455)
28. Studies on the biological activity of tocotrienols. K Komiyama K Iizuka M Yamaoka H Watanabe N Tsuchiya L Umezawa, Chem Pharm Bull 1989 37 1369 1371 2630104 (Pubitemid 19151240)
29. Tocotrienols inhibit the lipopolysaccharides-induced pro-inflammatory cytokines in murine macrophages and female mice. AA Qureshi JC Reis CJ Papasian DC Morrison N Qureshi, Lipids in Health and Disease 2010 9 143 10.1186/1476-511X-9-143 21162750
30. Tocotrienols in health and disease: The other half of the natural vitamin E family. CK Sen S Khanna S Roy, Molecular Aspects of Medicine 2007 28 692 728 10.1016/j.mam.2007.03.001 17507086 (Pubitemid 47625534)
31. Charcterization of potent neuroprotective properties of the natural vitamin E -tocotrienol. S Khanna S Roy NL Parinandi M Maurer CK Sen, J Neurochemistry 2006 98 1474 1486 10.1111/j.1471-4159.2006.04000.x (Pubitemid 44200439)
32. Cardioprotection with palm oil tocotrienols: Antioxidant activity of tocotrienol is linked with its ability to stabilize proteasome. S Das SR Powell P Wang A Divald K Nesaretam A Tosaki GA Cordis N Maulik DK Das, Am J Physiol Heart Circ Physiol 2005 289 361 H367 10.1152/ajpheart.01285.2004 15708953
33. 25) of rice bran in hypercholesterolemic humans. AA Qureshi SA Sami WA Salser FA Khan, Atherosclerosis 2002 161 199 207 10.1016/S0021-9150(01)00619-0 11882333 (Pubitemid 34214837)
34. Novel tocotrienols of rice bran inhibit Atherosclerotic lesions in C57BL/6 apo-deficient mice. AA Qureshi AW Salser R Parmer EE Emeson, J Nutr 2001 131 2606 2618 11584079 (Pubitemid 32947784)
35. Effects of administration of -tocopherol and tocotrienols on serum lipids and liver HMG-CoA reductase activity. HT Khor TT Ng, PORIM International PalmOil Congress (PIPOC), Nutrition Conference 1999 1 6 Febuary:177-186
36. Novel tocotrienols of rice bran modulate cardiovascular diseases risk parameters of hypercholesterolemic humans. AA Qureshi BA Bradlow WA Salser LD Brace, J Nutr Biochem 1997 8 290 298 10.1016/S0955-2863(97)89667-2 (Pubitemid 27305619)
37. Palm oil vitamin E effects in hypercholesterolemia, lipid soluble antioxidant. F Atroshi E Antila S Sankari J Treuthardt A Gapor, Biochemistry and Clinical Applications Birkhauser Verlag, Basel/Switzerland, Ong ASH, Packer L, 1995 575 581
38. Response of hypercholesterolemic subjects to administration of tocotrienols. AA Qureshi BA Bradlow L Brace J Manganello DM Peterson BC Pearce JJK Wright A Gapor CE Elson, Lipids 1995 30 1171 1177 10.1007/BF02536620 8614309
39. Tocotrienols, novel hypocholesterolemic agents with antioxidant Properties. N Qureshi AA Qureshi, Vitamin E in Health and Disease Mercel Dekker, Inc., New York, NY, Packer L, Fuchs J, 1993 247 267
40. An in vivo model of experimental arterial stenosis intimal damage, and periodic thrombosis. JD Folts, Circulation 1991 83IV V3 IV14
41. 25) of rice bran and lovastatin on lipid parameters hypercholesterolemic humans. AA Qureshi SA Sami WA Salser FA Khan, J Nutr Biochem 2001 12 318 329 10.1016/S0955-2863(01)00144-9 11516635 (Pubitemid 32552047)
42. In vivo models of arterial thrombosis and thrombolysis. LR Bush RJ Shebuski, FASEB J 1990 4 3087 3088 2210155
43. Administration of wine and grape juice Inhibits in vivo platelet activity and thrombosis in stenosed canine arteries. HS Demrow BS Peter R Slane JD Folts, Circulation 1995 91 1182 1188 7850957
44. Effects of aspirin and epinephrine on experimentally induced thrombogenesis in dogs: A parallelism between in vivo and ex vivo thrombosis model. P Sébastien KS Sakariassen VT Turitto HR Baumgarner, Arteriosclerosis and Thrombosis 11 1182 1191 119 1911705
45. Sodium nitroprusside, an EDRF cogener, Increases platelet cyclic GPP levels and inhibits epinephrine- exacerbated in vivo Platelet thrombus formation in stenosed canine coronary arteries. JD Rovin JS Stamler J Loscalzo JD Folts, J Cardiovasc Pharmacol 1993 22 626 631 10.1097/00005344-199310000-00017 7505366 (Pubitemid 23286760)
46. 2in mega-karyocytes. AC Chan M Wagner C Kennedy E Chen O Lanuville VA Mezi K Tran PC Choy, Mol Cell Biochem 1998 189 153 159 10.1023/A:1006954015678 9879666 (Pubitemid 28556560)
47. Restoration of prostacyclin/thromboxane balance in the diabetic rat. Influence of dietary vitamin E. CW Karpen KAJr Pritchard JH Arnold DG Cornwell RV Panganamala, Diabetes 1982 31 947 951 (Pubitemid 12005564)
48. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. A Theriault JT Chao A Gapor, Atherosclerosis 2002 160 21 30 10.1016/S0021-9150(01)00540-8 11755919 (Pubitemid 34076642)
49. Inhibition of platelet adherence to mononuclear cells by -tocopherol. T Murohara H Ikeda Y Otsuka M Aoki N Haramaki A Katoh Y Takajo T Imaizumi, Circulation 2004 110 141 148 10.1161/01.CIR.0000134485.30393.63 15197142 (Pubitemid 38924581)
50. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion on monocyte function and monocyte adhesion to endothelium. S Devaraj D Li I Jialal, J clin Investig 1996 98 756 763 10.1172/JCI118848 8698868 (Pubitemid 26349181)
51. -Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. JE Freedman JH Farhat J Loscalzo JFJ Keany, Circulation 1996 94 2434 2440 8921785 (Pubitemid 26403570)
52. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. M Liu A Wallmon C Olsson-Mortlock R Wallin T Saldeen, Am J Clin Nutr 2003 77 700 706 12600864 (Pubitemid 36258583)
53. Differential effects of alpa- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. T Saldeen D Li JL Mehta, J Am Coll Cardiol 1999 34 4 1208 1215 10.1016/S0735-1097(99)00333-2 10520814 (Pubitemid 29500562)
54. Antioxidant and anti-platelet effects of alpha-tocopherol-aspirin combination in type 1-like diabetic rats. JA Gonzlez-Correa MM Arrebola A Guerrero J Cãda J Mũoz-Marn F Snchez de la Cuesta JP De la Cruz, Life Sciences 2006 79 1405 1412 16737715
55. Interrelation of platelets vitamin E and thromboxane synthesis in type I diabetese mellitus. CW Karpen S Cataland TM O'Dorisio RV Panganamala, Diabetes 1984 33 239 243 10.2337/diabetes.33.3.239 6698315 (Pubitemid 14196213)
56. Production of 12- hydroxy-eicosatetraenoic acid and vitamin E status in platelet from type I human diabetic subjects. CW Karpen S Cataland TM O'Dorisio RV Panganamala, Diabetes 1985 34 526 531 10.2337/diabetes.34.6.526 3924690 (Pubitemid 15044155)
57. Platelet function in type I diabetes: Effects of supplementation with large doses of vitamin E. C Colette N Pares-Herbute LH Monnier E Carty, Am J Clin Nutr 1988 47 256 261 2963532 (Pubitemid 18091573)
58. Anti-inflammatory properties of - and - tocopherol. E Reiter Q Jiang S Christen, Molecular Aspects of Medicine 2007 28 668 691 10.1016/j.mam.2007.01. 003 17316780
59. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. S Khanna S Roy A Slivka TK Craft S Chaki C Rink MA Notestine AC DeVries NL Parinandi CK Sen, Stroke 2005 36 2258 2264 10.1161/01.STR.0000181082.70763.22 16166580 (Pubitemid 41429256)
60. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60 (c-Src) kinase activation and death of HT4 neural cells. CK Sen S Khanna s Roy L Packer, J Biol Chem 2000 275 13049 13055 10.1074/jbc.275.17.13049 10777609 (Pubitemid 30241466)
61. Cardioprotection with palm oil tocotrienols: Comparison of different isomers. S Das I Lekli M Das G Szabo J Varadi B Juhasz I Bak K Nesaretam A Tosaki SR Powell DK Das, Am J Physiol Heart Circ Physiol 2008 294 970 H978 10.1152/ajpheart.01200.2007 18083895
62. Comparison of palmolein and olive oil: Effects on plasma lipids and vitamin E in young adults. N Choudhury L Tan AS Truswell, Am J Clin Nutr 1995 61 1043 1051 7733026
63. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. AA Qureshi DM Peterson JO Hasler-Rapacz J Rapacz, J Nutr 2001 131 223 230 11160537 (Pubitemid 32115360)
64. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2 and platelet factor 4 in pigs with inherited hyperlipidemias. AA Qureshi N Qureshi JO Hasler-Rapacz FE Weber V Chaudhary TD Crenshaw A Gapor YH Chong ASH Ong DM Peterson J Rapacz, Am J Clin Nutr 1991 53 1042S 1046S 2012015 (Pubitemid 21898871)
65. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. PA Gum K Kottke-Merchant PA Welsh J White EJ Topol, J Am Coll Cardiol 2003 41 961 965 10.1016/S0735-1097(02)03014-0 12651041 (Pubitemid 36315537)
66. Clopidogrel resistance. A new chapter in a fast moving story. SD Wiviot EM Antman, Circulation 2004 109 3064 3067 10.1161/01.CIR.0000134701.40946.30 15226220